Prevalence of sicca symptoms in a South Australian cohort with systemic sclerosis

Internal Medicine Journal

Volumn 38, Issue 12, 2008, Pages 897-903

  Swaminathan, S ^a   Goldblatt, F ^b   Dugar, M ^a   Gordon, T P ^a   Roberts Thomson, P J ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Cholinergic antagonist; Muscarinic M3; Receptor; Systemic sclerosis; Thyroid disease

Indexed keywords

ANTIHISTAMINIC AGENT; AUTOANTIBODY; MUSCARINIC M3 RECEPTOR; NEUROLEPTIC AGENT; THYROXINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; REGISTRIES; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SOUTH AUSTRALIA;

EID: 58149188223     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01636.x     Document Type: Article

References (16)

1. Boin F Rosen A. Autoimmunity in systemic sclerosis: current concepts. Curr Rheumatol Rep 2007 9 : 165 72.
2. Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia et al. Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 2006 54 : 2243 9.
3. Goldblatt F, Gordon TP, Waterman SA. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 2002 123 : 1144 50.
4. Roberts-Thomson PJ, Jones M, Hakendorf P, Kencana Dharmapatni AA, Walker JG, MacFarlane JG et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J 2001 31 : 220 9.
5. Masi AT, Rodnan GP, Medsger TA, Altman RA, D'Angelo WA, Fries JF et al. Preliminary criteria for classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980 23 : 581 90.
6. Englert H, Small-McMahon J, Davis K, O'Connor H, Chambers P, Brooks P. Systemic sclerosis prevalence and mortality in Sydney 1974-88. Aust N Z J Med 1999 29 : 42 50.
7. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988 15 : 202 5.
8. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993 36 : 340 7.
9. Drosos AA, Andonopoulos AP, Costopoulos JS, Stavropoulos ED, Papadimitriou CS, Moutsopoulos HM. Sjogren's syndrome in progressive systemic sclerosis. J Rheumatol 1988 15 : 965 8.
10. Wangkaew S, Kasitanon N, Sivasomboon C, Wichainun R, Sukitawut W, Louthrenoo W. Sicca symptoms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma: a comparison with age-matched controls and correlation with disease variables. Asian Pac J Allergy Immunol 2006 24 : 213 21.
11. Salliot C, Mouthon L, Ardizzone M, Sibilia J, Guillevin L, Gottenberg JE et al. Sjogren's syndrome is associated with and not secondary to systemic sclerosis. Rheumatology 2007 46 : 321 6.
12. Bell S, Krieg T, Meurer M. Antibodies to Ro/SSA detected by ELISA: correlation with clinical features in systemic scleroderma. Br J Dermatol 1989 121 : 35 41.
13. Scully C. Drug effects on salivary glands: dry mouth. Oral Dis 2003 9 : 165 76.
14. Antonelli A, Ferri C, Fallahi P, Cazzato M, Ferrari SM, Sebastiani M et al. Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 2007 156 : 431 7.
15. Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis 2004 63 : 1159 61.
16. Mancel E, Janin A, Gosset D, Hatron PY, Gosselin B. Conjunctival biopsy in scleroderma and primary Sjogren's syndrome. Am J Ophthalmol 1993 115 : 792 9.